July 10, 2020
On Wednesday, June 17th, SNMMI hosted an FDA Townhall on the Impact of COVID-19 on regulatory activities. The purpose of this townhall was to provide information about the recent updates to submission mechanisms at the FDA, changes to facility inspections, and or regulatory changes due to COVID-19. The Coalition for PET Drugs participated in the townhall and facilitated the discussion of recent regulatory changes.
SNMMI thanks the FDA for being a partner in this townhall, along with allowing us to post the video file, slide deck, and answers to townhall Q&As for our members and industry partners.